In a recent study published in Nature, researchers developed the MK-801 bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models of metabolic illness by combining ...

Meanwhile, last week the Danish pharmaceutical powerhouse Novo Nordisk, which brought Ozempic into the spotlight, announced it would soon begin a human trial using the GLP-1 agonist drugs as a ...

Structure Therapeutics Inc. (GPCR) was able to report positive results from its phase 2a study using its GLP-1R agonist GSBR-1290 for the treatment of patients with obesity in June 2024. This is an ...

AbbVie is joining the chase for new obesity drugs, but rather than getting a me-too GLP-1 drug, the pharmaceutical giant is landing rights to a clinical-stage molecule that goes after two novel ...

When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in her appetite, but in how she thought about food. Where the smell of hot chips in the deep ...

Medically reviewed by Alex Yampolsky, PharmD Key Takeaways Ketamine is an anesthetic that can quickly reverse symptoms of depression but is not FDA approved for this use.Ketamine affects NMDA ...

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent ...